Steven H. Stein - Jul 15, 2024 Form 4 Insider Report for INCYTE CORP (INCY)

Role
EVP & Chief Medical Officer
Signature
/s/ Elizabeth Feeney
Stock symbol
INCY
Transactions as of
Jul 15, 2024
Transactions value $
-$99,909
Form type
4
Date filed
7/17/2024, 12:31 PM
Previous filing
Jul 3, 2024
Next filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INCY Common Stock Award $0 +13.9K +15.56% $0.00 103K Jul 15, 2024 Direct F1
transaction INCY Common Stock Tax liability -$99.9K -1.56K -1.51% $64.25 102K Jul 15, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Employee Stock Option (right to buy) Award $0 +31.1K $0.00 31.1K Jul 15, 2024 Common Stock 31.1K $64.25 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2 Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
F3 Including the July 15, 2024 grant, this includes an aggregate of 87,452 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
F4 The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.